Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP654234.RALQ0XjBQYzD4e2-_KQi8SM-sGylrqo7n-5BAHD4fdUD8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP654234.RALQ0XjBQYzD4e2-_KQi8SM-sGylrqo7n-5BAHD4fdUD8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP654234.RALQ0XjBQYzD4e2-_KQi8SM-sGylrqo7n-5BAHD4fdUD8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP654234.RALQ0XjBQYzD4e2-_KQi8SM-sGylrqo7n-5BAHD4fdUD8130_provenance.
- befree-20150227 importedOn "2015-02-27" NP654234.RALQ0XjBQYzD4e2-_KQi8SM-sGylrqo7n-5BAHD4fdUD8130_provenance.
- NP654234.RALQ0XjBQYzD4e2-_KQi8SM-sGylrqo7n-5BAHD4fdUD8130_assertion wasGeneratedBy ECO_0000203 NP654234.RALQ0XjBQYzD4e2-_KQi8SM-sGylrqo7n-5BAHD4fdUD8130_provenance.
- NP654234.RALQ0XjBQYzD4e2-_KQi8SM-sGylrqo7n-5BAHD4fdUD8130_assertion wasDerivedFrom befree-20150227 NP654234.RALQ0XjBQYzD4e2-_KQi8SM-sGylrqo7n-5BAHD4fdUD8130_provenance.
- NP654234.RALQ0XjBQYzD4e2-_KQi8SM-sGylrqo7n-5BAHD4fdUD8130_assertion SIO_000772 23222563 NP654234.RALQ0XjBQYzD4e2-_KQi8SM-sGylrqo7n-5BAHD4fdUD8130_provenance.
- NP654234.RALQ0XjBQYzD4e2-_KQi8SM-sGylrqo7n-5BAHD4fdUD8130_assertion evidence source_evidence_literature NP654234.RALQ0XjBQYzD4e2-_KQi8SM-sGylrqo7n-5BAHD4fdUD8130_provenance.
- NP654234.RALQ0XjBQYzD4e2-_KQi8SM-sGylrqo7n-5BAHD4fdUD8130_assertion description "[Signalling pathways known to be disrupted in UM include: (1) the retinoblastoma pathway, probably as a result of cyclin D1 overexpression; p53 signalling, possibly as a consequence of MDM2 overexpression; and the P13K/AKT and mitogen-activated protein kinase/extracellular signal-related kinase pathway pathways that are disturbed as a result of PTEN and GNAQ/11 mutations, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP654234.RALQ0XjBQYzD4e2-_KQi8SM-sGylrqo7n-5BAHD4fdUD8130_provenance.